Topical vitamin D3 derivatives in treating hyperkeratotic palmoplantar eczema: A report of five patients

Journal of Dermatology

Volumn 32, Issue 5, 2005, Pages 381-386

  Egawa, Kiyofumi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyperkeratotic; Palmoplantar eczema; Vitamin D3

Indexed keywords

22 OXACALCITRIOL; ANTIHISTAMINIC AGENT; BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; KERATOLYTIC AGENT; PETROLATUM; COLECALCIFEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ECZEMA; FEMALE; HUMAN; HYPERKERATOSIS; MALE; PHYSICAL EXAMINATION; SKIN BIOPSY; COMPARATIVE STUDY; EPIDEMIOLOGY; FOLLOW UP; HAND DISEASE; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; KERATOSIS; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PSORIASIS; RISK ASSESSMENT; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; BIOPSY, NEEDLE; CHOLECALCIFEROL; ECZEMA; FEMALE; FOLLOW-UP STUDIES; HAND DERMATOSES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS; MIDDLE AGED; PSORIASIS; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 21044444337     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00911.x     Document Type: Article

References (16)

1. Hersle K, Mobacken H: Hyperkeratotic dermatitis of the palm, Br J Dermatol, 107: 195-202, 1982.
2. Wilkinson JD: Vesicular palmoplantar eczema, in Freedberg IM, Eisen AZ, Wolff K, Goldsmith LA, Katz S, Fitzpatrick TB (eds): Dermatology in General Medicine, 5th ed, McGraw-Hill, New York, 1999, pp 1489-1494.
3. Gollnick H: New indications and new retinoids, Dermatologica, 175 (suppl 1): 182-195, 1987.
4. Thestrup-Pedersen K, Andersen KE, Menne T, Veien NK: Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study, Acta Derm Venereol, 81: 353-355, 2001.
5. Mobacken H, Rosen K, Swanbeck G: Oral psoralen photochemotherapy (PUVA) of hyperkeratotic dermatitis of the palm, Br J Dermatol, 109: 205-208, 1983.
6. Schempp CM, Mueller H, Czech W, et al: Treatment of chronic palmoplantar eczema with local bath-PUVA therapy, J Am Acad Dermatol, 36: 733-737, 1997.
7. 3, Arch Dermatol, 126: 1713, 1989.
8. 3 treatment in psoriasis vulgaris, Br J Dermatol, 115: 421-429, 1986.
9. van de Kerkhof PCM: Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms, Br J Dermatol, 132: 675-682, 1995.
10. Osborne JE, Hutchinson PE: Vitamin D and systemic cancer: is this relevant to malignant melanoma?, Br J Dermatol, 147: 197-213, 2002.
11. Mason J, Mason AR, Cork MJ: Topical preparations for the treatment of psoriasis: a systematic review, Br J Dermatol, 146: 351-364, 2002.
12. Dubertret L, Wallach D, Souteyrand P, et al: Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study, J Am Acad Dermatol, 27: 983-988, 1992.
13. Barker JNWN, Ashton RE, Marks R, et al: Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator, Br J Dermatol, 141: 274-278, 1999.
14. Lucker GPH, van de Kerkhof PCM, Steijlen PM: Topical calcipotriol in the treatment of epidermolytic palmoplantar keratoderma of Voerner, Br J Dermatol, 130: 543-545, 1994.
15. 3 inhibits pro-inflammatory cytokine and chemochine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa, Immunol Cell Biol, 80: 340-345, 2002.
16. 3 on the activation of dendritic cells stimulated by haptens, Arch Dermatol Res, 291: 548-554, 1999.